Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures. (Q47727040)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Mauro Di Bari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Giuseppina Campisi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

12

M Brandi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

F Lapi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

F Cipriani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A P Caputi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

G Corrao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Vaccheri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M C Sturkenboom

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

F Carle

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

T Staniscia

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Vestri

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

V Fusco

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

G Mazzaglia

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

23 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

number of pages

9

1 reference

Osteoporosis International

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

697-705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-012-2013-y

2 February 2020

exact match

0 references

cites work

Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Osteonecrosis of the jaw--do bisphosphonates pose a risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Hip fractures in Italy: 2000-2005 extension study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Identification and validation of vertebral compression fractures using administrative claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

"Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Misclassification of exposure is high when interview data on drug use are used as a proxy measure of chronic drug use during follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

The performance of different propensity-score methods for estimating relative risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-012-2013-Y

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update

21 January 2018

1 reference

12 December 2020

Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study

1 reference

12 December 2020

Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw

1 reference

12 December 2020

Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.

1 reference

12 December 2020

NICE recommendations for the prevention of osteoporotic fractures in postmenopausal women

1 reference

12 December 2020

Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study.

1 reference

12 December 2020

10.1007/S00198-012-2013-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22618266%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference